<?xml version="1.0" encoding="UTF-8"?>
<p>A simple but very effective treatment modality is the use of convalescent plasma, or serum from patients who have recovered from the virus, to treat patients. Patients with resolved viral infection will have developed a specific antibody response which may be helpful in neutralizing viruses in newly infected individuals. This modality was successfully employed during the 2014â€“2015 Ebola outbreak [
 <xref rid="B65-pathogens-09-00231" ref-type="bibr">65</xref>,
 <xref rid="B66-pathogens-09-00231" ref-type="bibr">66</xref>]. However, the use of convalescent sera is of limited benefit in an outbreak situation since the exponential growth of infected patients exceeds the ability of previous patients to provide donor plasma.
</p>
